Predictive factors for a severe clinical course in ulcerative colitis: Results from population-based studies
- PMID:27158539
- PMCID: PMC4848246
- DOI: 10.4292/wjgpt.v7.i2.235
Predictive factors for a severe clinical course in ulcerative colitis: Results from population-based studies
Abstract
Ulcerative colitis (UC) is characterized by chronic inflammation of the large bowel in genetically susceptible individuals exposed to environmental risk factors. The disease course can be difficult to predict, with symptoms ranging from mild to severe. There is no generally accepted definition of severe UC, and no single outcome is sufficient to classify a disease course as severe. There are several outcomes indicating a severe disease course, including progression of the disease's extension, a high relapse rate, the development of acute severe colitis, colectomy, the occurrence of colorectal cancer and UC-related mortality. When evaluating a patient's prognosis, it is helpful to do so in relation to these outcomes. Using these outcomes also makes it easier to isolate factors predictive of severe disease. The aims of this article are to evaluate different disease outcomes and to present predictive factors for these outcomes.
Keywords: Acute severe colitis; Cancer; Colectomy; Disease course; Mortality; Prognosis; Relapse; Severity; Ulcerative colitis.
Similar articles
- Clinical course of ulcerative colitis.Cottone M, Scimeca D, Mocciaro F, Civitavecchia G, Perricone G, Orlando A.Cottone M, et al.Dig Liver Dis. 2008 Jul;40 Suppl 2:S247-52. doi: 10.1016/S1590-8658(08)60533-2.Dig Liver Dis. 2008.PMID:18598996Review.
- Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.Chatzinasiou F, Polymeros D, Panagiotou M, Theodoropoulos K, Rigopoulos D.Chatzinasiou F, et al.Acta Dermatovenerol Croat. 2016 Apr;24(1):83-5.Acta Dermatovenerol Croat. 2016.PMID:27149138
- Cyclosporine A for induction of remission in severe ulcerative colitis.Shibolet O, Regushevskaya E, Brezis M, Soares-Weiser K.Shibolet O, et al.Cochrane Database Syst Rev. 2005 Jan 25;(1):CD004277. doi: 10.1002/14651858.CD004277.pub2.Cochrane Database Syst Rev. 2005.PMID:15674937Review.
- Surgery in ulcerative colitis: When? How?Gallo G, Kotze PG, Spinelli A.Gallo G, et al.Best Pract Res Clin Gastroenterol. 2018 Feb-Apr;32-33:71-78. doi: 10.1016/j.bpg.2018.05.017. Epub 2018 Jun 14.Best Pract Res Clin Gastroenterol. 2018.PMID:30060941Review.
- Presenting features and disease course of pediatric ulcerative colitis.Aloi M, D'Arcangelo G, Pofi F, Vassallo F, Rizzo V, Nuti F, Di Nardo G, Pierdomenico M, Viola F, Cucchiara S.Aloi M, et al.J Crohns Colitis. 2013 Dec;7(11):e509-15. doi: 10.1016/j.crohns.2013.03.007. Epub 2013 Apr 11.J Crohns Colitis. 2013.PMID:23583691
Cited by
- Exposure time determines the protective effect of Trichinella spiralis on experimental colitis.Zheng W, Ma Z, Sun X, Huang Y, Lu B, Chen X, Xue X, Yang X, Wu X.Zheng W, et al.Microb Pathog. 2020 Oct;147:104263. doi: 10.1016/j.micpath.2020.104263. Epub 2020 May 20.Microb Pathog. 2020.PMID:32442663Free PMC article.
- The Role of Cyclophilins in Inflammatory Bowel Disease and Colorectal Cancer.Liang L, Lin R, Xie Y, Lin H, Shao F, Rui W, Chen H.Liang L, et al.Int J Biol Sci. 2021 Jun 16;17(10):2548-2560. doi: 10.7150/ijbs.58671. eCollection 2021.Int J Biol Sci. 2021.PMID:34326693Free PMC article.Review.
- Clinical Characteristics and Long-term Outcomes of Pediatric Ulcerative Colitis: A Single-Center Experience in Korea.Jang J, Lee SH, Jeong IS, Cho J, Kim HJ, Oh SH, Kim DY, Lee HS, Park SH, Ye BD, Yang SK, Kim KM.Jang J, et al.Gut Liver. 2022 Mar 15;16(2):236-245. doi: 10.5009/gnl20337.Gut Liver. 2022.PMID:34238767Free PMC article.
- Gastrointestinal dysbiosis and Escherichia coli pathobionts in inflammatory bowel diseases.Petersen AM.Petersen AM.APMIS. 2022 Aug;130 Suppl 144(Suppl 144):1-38. doi: 10.1111/apm.13256.APMIS. 2022.PMID:35899316Free PMC article.No abstract available.
- A new opportunity for innovative inflammatory bowel disease research: the moderate-to-severe ulcerative colitis in Korea (MOSAIK) cohort study.Lee CK, Lee KM, Park DI, Jung SA, Jeen YT, Park YS, Kim HJ; MOSAIK study group of the Korean Association for the Study of Intestinal Diseases (KASID).Lee CK, et al.Intest Res. 2019 Jan;17(1):1-5. doi: 10.5217/ir.2019.00005. Epub 2019 Jan 25.Intest Res. 2019.PMID:30678443Free PMC article.No abstract available.
References
- Ordás I, Eckmann L, Talamini M, Baumgart DC, Sandborn WJ. Ulcerative colitis. Lancet. 2012;380:1606–1619. - PubMed
- Moum B, Ekbom A, Vatn MH, Elgjo K. Change in the extent of colonoscopic and histological involvement in ulcerative colitis over time. Am J Gastroenterol. 1999;94:1564–1569. - PubMed
- Solberg IC, Lygren I, Jahnsen J, Aadland E, Høie O, Cvancarova M, Bernklev T, Henriksen M, Sauar J, Vatn MH, et al. Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study) Scand J Gastroenterol. 2009;44:431–440. - PubMed
Publication types
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources